BIOMAT Database Logo BIOMAT Database Logo

Anticonvulsant properties of some new derivatives of phensuccinimide. 1979

S Rump, and I Ilczuk, and K Walczyna

Anticonvulsant properties of two new derivatives, of phenylsuccinimide, N-morpholinomethyl-3-bromophenyl-succinimide(IL-7) and N-amino-3-bromophenylsuccinimide (IL-16), were studied. It was stated that both compounds have similar acute toxicity and act longer than phensuximide. They are especially active in maximal electroshock seizure (MES) test. Their effectiveness against convulsions produced by pentetrazole is less than that of phensuximide. Their effectiveness against procaine and strychnine is similar, only one of tested compounds has very high potency against strychnine. This compound, IL-16, has also a different pattern of effect-time which is probably due to its different pharmacokinetic behaviour.

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D010433 Pentylenetetrazole A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility. Leptazole,Pentamethylenetetrazole,Pentetrazole,Cardiazol,Corasol,Corazol,Corazole,Korazol,Korazole,Metrazol,Metrazole,Pentazol,Pentylenetetrazol
D011343 Procaine A local anesthetic of the ester type that has a slow onset and a short duration of action. It is mainly used for infiltration anesthesia, peripheral nerve block, and spinal block. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1016). Anuject,Geriocaine,Gerokit,Hewedolor-Procain,Lophakomp-Procain N,Novocain,Novocaine,Procain Braun,Procain Jenapharm,Procain Rödler,Procain Steigerwald,Procain curasan,Procaina Serra,Procaine Hydrochloride,Pröcaine chlorhydrate Lavoisier,Röwo Procain,procain-loges,Hydrochloride, Procaine
D004597 Electroshock Induction of a stress reaction in experimental subjects by means of an electrical shock; applies to either convulsive or non-convulsive states. Electroconvulsive Shock,Electroconvulsive Shocks,Electroshocks,Shock, Electroconvulsive,Shocks, Electroconvulsive
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic
D013331 Strychnine An alkaloid found in the seeds of STRYCHNOS NUX-VOMICA. It is a competitive antagonist at glycine receptors and thus a convulsant. It has been used as an analeptic, in the treatment of nonketotic hyperglycinemia and sleep apnea, and as a rat poison. Strychnine Nitrate,Nitrate, Strychnine
D013388 Succinimides A subclass of IMIDES with the general structure of pyrrolidinedione. They are prepared by the distillation of ammonium succinate. They are sweet-tasting compounds that are used as chemical intermediates and plant growth stimulants. Butanimides,Pyrrolidinediones
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

S Rump, and I Ilczuk, and K Walczyna
Synthesis and anticonvulsant properties of new benzylpyridazine derivatives.
July 1994, Journal of medicinal chemistry,
S Rump, and I Ilczuk, and K Walczyna
EXPERIMENTAL DETERMINATION OF THE ANTICONVULSANT PROPERTIES OF SOME PHENYL DERIVATIVES.
May 1937, Science (New York, N.Y.),
S Rump, and I Ilczuk, and K Walczyna
Synthesis and anticonvulsant activity of some new dioxolane derivatives.
January 2003, Arzneimittel-Forschung,
S Rump, and I Ilczuk, and K Walczyna
Some new piperazino derivatives as antiparkinson and anticonvulsant agents.
August 1983, Archiv der Pharmazie,
S Rump, and I Ilczuk, and K Walczyna
Evaluation of some 2-substituted derivatives of xanthone for anticonvulsant properties.
June 1998, Die Pharmazie,
S Rump, and I Ilczuk, and K Walczyna
Synthesis and anticonvulsant properties of some 2-aminoethanesulfonic acid (taurine) derivatives.
January 1984, Journal of pharmaceutical sciences,
S Rump, and I Ilczuk, and K Walczyna
ANTICONVULSANT PROPERTIES OF SOME BENZODIAZEPINE DERIVATIVES. POSSIBLE USE AGAINST PSYCHOMOTOR SEIZURES.
March 1965, Neurology,
S Rump, and I Ilczuk, and K Walczyna
Anticonvulsant activity of some xanthone derivatives.
August 2008, Bioorganic & medicinal chemistry,
S Rump, and I Ilczuk, and K Walczyna
Synthesis and properties of cyclic derivatives of phenylsuccinic acid. IX. New phenylsuccinimide derivatives with anticonvulsant properties.
January 1987, Acta poloniae pharmaceutica,
S Rump, and I Ilczuk, and K Walczyna
Synthesis and properties of cyclic derivatives of phenylsuccinic acid. VII. New phenylsuccinimide derivatives with anticonvulsant properties.
January 1978, Acta poloniae pharmaceutica,
Copied contents to your clipboard!